On 2026-08-11, Hemab Therapeutics Holdings, Inc. (COAG) announced earnings per share of $-0.80 for the fiscal quarter ending 2026-06-30, missing the average analyst estimate of $-0.63.

The next expected annoucement date for quarterly earnings is 2026-11-10, with an average estimated earnings per share of $-0.50 for the fiscal quarter ending 2026-09-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.